首页> 外文期刊>Allergy >Histamine H_4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge
【24h】

Histamine H_4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge

机译:组胺H_4受体拮抗剂可缓解反复刺激引起的慢性过敏性接触性皮炎

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The present study observed effects of the histamine H_4 receptor on chronic allergic contact dermatitis induced by repeated challenge in mice. Methods: Acute contact dermatitis was induced by single epicutaneous challenge of 2,4,6-trinitro-l-chlorobenzene (TNCB) to the ear. Chronic allergic contact dermatitis was developed by repeated epicutaneous challenge using TNCB on the dorsal back skin. H_4 receptor antagonist JNJ7777120 was administered to wild-type mice, while H_4 receptor agonist 4-methylhistamine was administered to histidine decarboxylase(HDC) (-/-) mice that synthesized no histamine.Results: HDC (-/-) mice did not differ phenotypically from HDC ( + / + ) mice, and H_4 receptor antagonist/agonist did not have clinical effects in terms of acute contact dermatitis reactions. H_4 receptor antagonist ameliorated skin eczematous lesions induced by repeated TNCB challenge in HDC (+ / +) mice. On the contrary, H_4 receptor agonist exacerbated skin lesions exclusively in HDC (-/-) mice. Application of H_4 receptor agonist induced migration of mast cells and eosinophils in skin lesions, and H_4 receptor antagonist suppressed these changes. H_4 receptor was immunohistochemically detected on mast cells in eczematous lesions. Levels of inter-leukin (IL)-4, -5, and -6 in lesions were decreased, whereas levels of interferon-y and IL-12 were increased by H_4 receptor antagonistic activity. Serum Immunoglobulin E levels rapidly increased with repeated challenge, but decreased with H_4 receptor antagonist.Conclusion: Because chronic allergic contact dermatitis is developed by H_4 receptor stimulation, H_4 receptor antagonists might represent new candidate drugs for treating chronic allergic contact dermatitis.
机译:背景:本研究观察了组胺H_4受体对小鼠反复攻击引起的慢性过敏性接触性皮炎的作用。方法:急性2,4,6-三硝基-1-氯苯(TNCB)经表皮刺激后,会引起急性接触性皮炎。慢性过敏性接触性皮炎是通过在背部背部皮肤上反复使用TNCB进行表皮刺激而发展而来的。对野生型小鼠施用H_4受体拮抗剂JNJ7777120,对不合成组胺的组氨酸脱羧酶(HDC)(-/-)小鼠施用H_4受体激动剂4-甲基组胺。结果:HDC(-/-)小鼠没有差异从HDC(+ / +)小鼠的表型上看,H_4受体拮抗剂/激动剂在急性接触性皮炎反应方面没有临床效果。 H_4受体拮抗剂改善了HDC(+ / +)小鼠反复TNCB刺激引起的皮肤湿疹病变。相反,H_4受体激动剂仅在HDC(-/-)小鼠中加剧了皮肤损伤。 H_4受体激动剂的应用引起皮肤病变中肥大细胞和嗜酸性粒细胞的迁移,而H_4受体拮抗剂抑制了这些变化。在湿疹性病变的肥大细胞中免疫组织化学检测到H_4受体。 H_4受体拮抗活性使病变中白介素(IL)-4,-5和-6的水平降低,而γ-干扰素和IL-12的水平升高。血清免疫球蛋白E水平随着反复攻击而迅速升高,但随着H_4受体拮抗剂的下降而降低。结论:由于慢性过敏性接触性皮炎是由H_4受体刺激产生的,因此H_4受体拮抗剂可能代表了治疗慢性过敏性接触性皮炎的新候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号